Medulloblastoma Comprises Four Distinct Molecular VariantsPaul A. Northcott, Michael D. Taylor, Andrey Korshunov et al.|Journal of Clinical Oncology|2010Cited by 1.4k
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M. Thompson, Tibor Hortobágyi, Gerald A. Grant et al.|The Lancet Oncology|2016Cited by 369
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort AnalysisVijay Ramaswamy, Ralph P. Ermoian, Thomas Hielscher et al.|Journal of Clinical Oncology|2016Cited by 206
The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic AstrocytomaJuliane L. Buhl, Till Milde, Florian Selt et al.|Clinical Cancer Research|2018Cited by 84
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemiaCornelis M. van Tilburg, Olaf Witt, Till Milde et al.|Clinical Epigenetics|2019Cited by 44